Javascript must be enabled to continue!
Technology scanning for water reuse in small water systems: needs, application, and decision support
View through CrossRef
ABSTRACT
3 panels connected by arrows under the words WATER-MAP. Left panel shows barriers to reuse. Central panel shows selection criteria and technologies. Third panel show reuse applications in small communities.
Water reuse has been successful in many major cities, but small communities remain systemically disadvantaged in the implementation of water reuse due to limited resources and support. Limited access to relevant data on treatment technologies is one key impediment to the adoption of water reuse in small water systems. We developed an open-access technology scan to compile and communicate essential attributes of technologies appropriate for water reuse in small water systems. We determined the necessary content of such a technology scan, identified demand sectors, and investigated its feasibility through development of a proof-of-concept tool. We conducted interviews to understand the evaluation process for water treatment technologies in small systems. We then developed a framework to assess reuse technologies by costs, labor requirements, and the achievement of regulatory compliance: all primary considerations in small systems. The resulting Water Augmentation Technology Evaluation & Reuse Management Platform (WATER-MAP) organizes technologies based on critical evaluation factors, technical readiness, and existing implementations. WATER-MAP drew data from manufacturers, EPA and water association tools, literature, and utilities to identify treatment technologies relevant for small systems. We demonstrate the feasibility of an open-source technology scan that provides essential information for evaluating water reuse technologies in small communities.
Title: Technology scanning for water reuse in small water systems: needs, application, and decision support
Description:
ABSTRACT
3 panels connected by arrows under the words WATER-MAP.
Left panel shows barriers to reuse.
Central panel shows selection criteria and technologies.
Third panel show reuse applications in small communities.
Water reuse has been successful in many major cities, but small communities remain systemically disadvantaged in the implementation of water reuse due to limited resources and support.
Limited access to relevant data on treatment technologies is one key impediment to the adoption of water reuse in small water systems.
We developed an open-access technology scan to compile and communicate essential attributes of technologies appropriate for water reuse in small water systems.
We determined the necessary content of such a technology scan, identified demand sectors, and investigated its feasibility through development of a proof-of-concept tool.
We conducted interviews to understand the evaluation process for water treatment technologies in small systems.
We then developed a framework to assess reuse technologies by costs, labor requirements, and the achievement of regulatory compliance: all primary considerations in small systems.
The resulting Water Augmentation Technology Evaluation & Reuse Management Platform (WATER-MAP) organizes technologies based on critical evaluation factors, technical readiness, and existing implementations.
WATER-MAP drew data from manufacturers, EPA and water association tools, literature, and utilities to identify treatment technologies relevant for small systems.
We demonstrate the feasibility of an open-source technology scan that provides essential information for evaluating water reuse technologies in small communities.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...
Increasing water system robustness: potential of cross-sectoral water reuse
Increasing water system robustness: potential of cross-sectoral water reuse
<p>We are increasingly confronted with drought damage in agriculture and nature as well as an increasing pressure on the availability of water for high-grade applicat...
ReUse/Web: Web-based Ada reuse
ReUse/Web: Web-based Ada reuse
In his article "Software Reuse Myths" from the January 1988 issue of
ACM SIGSOFT Software Engineering Notes,
Will Tracz discusses why software reuse has not...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
openEHR Archetypes Reuse Analysis of Clinical Knowledge Manager Instances: Case Study (Preprint)
openEHR Archetypes Reuse Analysis of Clinical Knowledge Manager Instances: Case Study (Preprint)
BACKGROUND
Electronic health record information systems' continuous application has accumulated enormous medical data with potential value. Semantic interop...

